Unum Therapeutics Inc. | 200 Cambridge Park Drive Suite 3100 | Cambridge, MA 02140  USA

Tel. +1.617.945.5576 | Email: info@unumrx.com

  • LinkedIn - White Circle
  • Twitter - White Circle

© Copyright 2014-2019 Unum Therapeutics

The distinguished translational oncology researchers on Unum’s Scientific Advisory Board (SAB) provide counsel to support continued development of our ACTR platform, and provide us with key insights as we develop our broader research agenda. Comprised of pioneers in immuno-oncology, our SAB includes:

 

 

Dario Campana, MD, PhD
Chair

Bio

 

Malcom Brenner, MD, PhD

Bio

 

John Gribben, MD, DSc, FRCP, FRCPath, FMedSci

Bio

 

Crystal Mackall, MD

Bio

John Gribben, MD, DSc, FRCP, FRCPath, FMedSci

 

Dr. Gribben currently serves as Professor of Medical Oncology; Director of the Centre of Hemato-Oncology; and Director of Stem Cell Transplantation at Saint Bartholomew's Hospital, Queen Mary, University of London School of Medicine. An internationally recognized translational researcher, his primary research interests include cancer immunotherapies and new treatments for B cell malignancies. His laboratory focuses on the role of the tumor microenvironment as a target for new therapeutic approaches.